Tag: Africa

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering […]

Read More

AI-Media and ITV Announce Landmark Partnership to Revolutionize Captioning Services

LONDON, Sept. 10, 2024 (GLOBE NEWSWIRE) — AI-Media, the global leader in AI-powered captioning and translation services, is proud to announce a new partnership with ITV, the UK’s largest commercial broadcaster. This collaboration marks a significant step forward in the use of AI captioning technology to enhance accessibility and operational efficiency across ITV’s extensive broadcast […]

Read More

Akur8 Expands Core Capabilities with Strategic Acquisition of Arius® Reserving Solution

Akur8 acquires Arius Bringing the Best Reserving Solution In-House for Unmatched Innovation PARIS, NEW YORK and ATLANTA, Sept. 09, 2024 (GLOBE NEWSWIRE) — Akur8, the next generation insurance pricing solution powered by transparent machine learning, is thrilled to announce its acquisition of Arius®, an award-winning P&C reserving software for insurers and reinsurers, known for its […]

Read More

JMGO Set to Ace Laser Projection with MALC™ 2.0 Triple Laser Optics at IFA 2024

Setting new standards for the projector industry with epic brightness, contrast, and color reproduction—achieved all at once JMGO Set to Ace Laser Projection with MALC™ 2.0 Triple Laser Optics at IFA 2024 BERLIN, Sept. 04, 2024 (GLOBE NEWSWIRE) —  JMGO, a pioneer in optical technology, will showcase its in-house developed MALC™ (Microstructure Adaptive Laser Control) […]

Read More

Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability

REC-994 also demonstrates encouraging trends in objective MRI-based exploratory efficacy measures at the highest dose and the company plans to advance development of REC-994 for the potential treatment of symptomatic CCM in subsequent studies. SALT LAKE CITY, Sept. 03, 2024 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to […]

Read More

Bitget Proof-of-Reserves August: Increase in Reserve Ratio and Users’ Asset in Ethereum (ETH)

VICTORIA, Seychelles, Aug. 29, 2024 (GLOBE NEWSWIRE) — Bitget, the world’s leading cryptocurrency exchange and Web3 company, has shared its monthly update for the transparent tracking of its proof-of-reserves (PoR) highlighting the reserve ratios of Bitcoin (BTC), Ethereum (ETH), USDT and USDC. This update shows the platform’s commitment to transparency and security, highlighting significant growth in […]

Read More